文献速递关节外科创伤骨科

二期翻修膝关节假体周围感染中抗生素骨水泥间隔器置入后急性肾损伤的回溯性队列研究

Acute Kidney Injury Following Antibiotic-Loaded Spacer Insertion in Two-Stage Knee Arthroplasty Revision for Periprosthetic Joint Infection: A Retrospective Cohort Study.
PubMed 文献 · J Arthroplasty · 2026-07-06

本研究回顾性纳入152例接受二期翻修全膝关节置换术并使用超高剂量抗生素骨水泥间隔器(通常每40克骨水泥含8克抗生素)的患者,采用患者自身对照设计。结果显示,第一期术后急性肾损伤(AKI)发生率为6.6%,第二期为2.6%(P=0.10),86%的AKI病例在一个月内恢复至基线水平,仅2例AKI患者存在既往慢性肾病。结论认为超高剂量抗生素骨水泥间隔器方案安全有效,多数AKI为一过性且与慢性肾病无关。

要点

  • 超高剂量抗生素骨水泥间隔器(平均8.5克/袋)在二期翻修TKA中AKI总体发生率较低。
  • 第一期术后AKI发生率为6.6%,第二期为2.6%,两期之间无显著差异(P=0.10)。
  • 86%的AKI病例在一个月内恢复至基线,仅2例AKI患者有既往慢性肾病。

核心结论

  • 超高剂量抗生素骨水泥间隔器方案对于处理TKA后假体周围感染是安全有效的。
  • 大多数AKI病例为一过性,且与慢性肾病无关,提示其他可调控的围手术期因素可能起更大作用。
  • 兼顾安全性与有效性的精确剂量尚未确定。

研究设计与样本

  • 回顾性队列研究,纳入2004年至2023年间在单一高容量学术中心接受二期翻修TKA并使用超高剂量抗生素骨水泥间隔器方案(通常每40克骨水泥含8克抗生素)的152例患者。
  • 纳入标准为两期手术均有术前和术后肌酐记录的患者,采用患者自身对照设计,AKI按KDIGO标准定义。

主要发现

  • 总体平均随访时间为7.9±4.3年。
  • 73%的患者间隔器每袋骨水泥抗生素剂量≥8克(平均8.5克/袋)。
  • 第一期术后AKI发生率为6.6%(10/152),第二期为2.6%(4/152),P=0.10。
  • 重复测量方差分析未显示第一期与第二期之间患者内肌酐变化有显著差异。
  • 无患者在两期均发生AKI;AKI病例中86%在一个月内恢复至基线;仅2例AKI患者有既往慢性肾病;万古霉素(87.1%)和头孢他啶(85.7%)是最常添加的抗生素。

关键数值与推荐

  • AKI定义采用KDIGO标准。
  • 超高剂量抗生素骨水泥间隔器方案通常为每40克骨水泥含8克抗生素,73%患者≥8克/袋,平均8.5克/袋。
  • 第一期术后AKI发生率6.6%(10/152),第二期2.6%(4/152),P=0.10。
  • AKI病例中86%在一个月内恢复至基线。
  • 最常添加的抗生素为万古霉素(87.1%)和头孢他啶(85.7%)。

临床怎么用

  • 在二期翻修TKA中可考虑使用超高剂量抗生素骨水泥间隔器,但需监测肾功能。
  • 多数AKI为一过性且一个月内恢复,术前慢性肾病并非主要风险因素。
  • 需关注其他可调控的围手术期因素以降低AKI风险。

局限性

  • 回顾性研究设计。
  • 单中心研究。
  • 仅纳入有肌酐记录的患者可能存在选择偏倚。
  • 精确的安全有效剂量尚未确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antibiotic-loaded cement spacers (ACS) are integral to two-stage revision total knee arthroplasty (TKA) for periprosthetic joint infection. While effective in infection eradication, concerns have emerged regarding nephrotoxicity due to systemic absorption of high-dose antibiotics. This study aimed to determine the incidence and risk factors for acute kidney injury (AKI) following very high-dose ACS insertion in two-stage revision TKA using a within-patient controlled design. METHODS: We conducted a retrospective cohort study of 152 patients who underwent two-stage revision TKA with a very high-dose ACS protocol (typically eight grams (g) of antibiotics per 40 grams of cement) at a single high-volume academic center between 2004 and 2023. Patients with recorded preoperative and postoperative creatinine values for both stages were included. An AKI was defined per KDIGO criteria. Each patient served as their own control. RESULTS: The overall mean follow-up was 7.9 ± 4.3 years. Of the patients, 73% had a spacer with ≥ eight grams of antibiotics per bag of cement (mean = 8.5 g/bag). An AKI occurred in 6.6% (10 of 152) of patients after the first stage and 2.6% (four of 152) after the second stage (P = 0.10). Repeated measures analysis of variance did not reveal a significant difference in the within-patient creatinine changes between the first and second stages. There were no patients who experienced AKI in both stages. Among AKI cases, 86% resolved to baseline within one month. Only two of the patients who had AKI had preexisting chronic kidney disease. Vancomycin (87.1%) and ceftazidime (85.7%) were the most common antibiotics added to the very high-dose spacers. CONCLUSIONS: A very high-dose ACS protocol is safe and effective for managing periprosthetic joint infection following TKA. Most AKI cases were transient and unrelated to chronic kidney disease, suggesting other modifiable perioperative factors may play a greater role. The precise dosage that optimizes both safety and efficacy has yet to be determined.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Tchouambou Youmbi C, Santos A, Bridger A, et al. Acute Kidney Injury Following Antibiotic-Loaded Spacer Insertion in Two-Stage Knee Arthroplasty Revision for Periprosthetic Joint Infection: A Retrospective Cohort Study. J Arthroplasty. 2026. PMID: 42409293. doi:10.1016/j.arth.2026.06.084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。